<DOC>
	<DOCNO>NCT00847587</DOCNO>
	<brief_summary>A highly effective single rod contraceptive implant available use US . Delays insertion device later postpartum period may negatively impact initiation rate . The objective study compare outcomes early postpartum insertion ( prior postpartum hospital discharge ) etonogestrel-releasing contraceptive implant routine postpartum insertion 4-8 week delivery . Primary outcome interest time lactogenesis . Secondary outcome include rate breastfeed supplementation , infant growth , vaginal bleeding pattern , incidence side effect , time resume sexual intercourse delivery , incidence miss routine postpartum follow-up . In addition , subset patient randomize early postpartum insertion express breastmilk ascertain nutrient composition .</brief_summary>
	<brief_title>Early Versus Standard Postpartum Insertion Etonogestrel Contraceptive Implant</brief_title>
	<detailed_description>This randomize controlled trial . Participants assign equal probability 1 2 test group use computer-generated random number block vary size . Allocation concealment assure enclose assignment sequentially number , opaque , seal envelope . Envelopes open sequentially participant 's name study number write envelope . Follow-up data collection participant group identical . Outcome assessor data analyst blind treatment arm . STUDY PROCEDURES : Inclusion/exclusion criterion verify consent obtain . The patient notify result randomization physician able perform insertion contact perform insertion . All insertion perform physician complete Implanon® insertion training . If patient randomize standard postpartum insertion , give clinic appointment 4-8 week insertion procedure . Lactogenesis time document maternal perception , describe validated Chapman et al16 . If lactogenesis occur prior hospital discharge , patient receive daily phone call study personnel lactogenesis confirm record . Contact information patient , well two friend relative know reach obtain verified prior discharge . Participants give reminder card telephone call investigator postpartum visit appointment . Patients instructed contact investigator immediately pain , excessive bleeding , difficulty breastfeeding , concern . Patients give log book ( `` diary '' ) record breastfeed parameter include use supplementation , infant weight , side effect , return sexual intercourse , contraceptive method use , day bleed study follow-up period . Clinical follow-up follow . Postpartum telephone call visit collect additional data occur need 5 day follow hospital discharge , 2 week , 4-8 week , 3 6 month postpartum . Information obtain point include : breastfeeding status parameter , collection record infant weight ( birth , 4-8 week , 6 month ) , reminder keep weekly diary , collection diary ( 6 month visit ) , resumption sexual activity , use contraceptive method , satisfaction contraceptive method . Patients randomize early insertion ask give milk sample analysis 4-8 week visit . Table 1 describes contact point subject collection data . Contact either telephone clinic visit .</detailed_description>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>Patients postpartum ward University Hospital offer inclusion study : healthy , 1840 year old , deliver healthy term infant , intend breastfeed , desire Implanon method contraception , agree randomize early versus standard postpartum insertion . obstetric complication include anemia hematocrit &lt; 30 , transfusion , infection , severe pregnancy induced hypertension , prolonged hospitalization , coagulopathy , liver disease , undiagnosed genital bleeding , relative contraindication Implanon® insertion ( know suspect pregnancy , know , suspect , history breast cancer , hypersensitivity component Implanon® ) . Women take drug potent inducer hepatic enzyme also exclude , include barbiturate , griseofulvin , rifampin , phenylbutazone , phenytoin , carbamazepine , felbamate , oxcarbazepine , topiramate , modafinil , protease inhibitor , herbal product include St. John 's Wort .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Contraceptive</keyword>
	<keyword>Implant</keyword>
	<keyword>Postpartum period</keyword>
	<keyword>etonogestrel-releasing</keyword>
	<keyword>lactogenesis</keyword>
	<keyword>Breastfeeding</keyword>
</DOC>